Markets

Moderna shares double as cancer vaccine data rekindles investor hopes

2 sources ·2 articles ·1h ago

2 outlets - including Ft and Yahoo - are covering this story. Drugmaker’s melanoma shot developed with Merck delivers positive outcome in late-stage trial

Covered by 2 outlets

Ft 1 Yahoo 1

All coverage · 2 articles

Financial Times - Companies ·1h ago

Moderna shares double on skin cancer vaccine success

Drugmaker’s melanoma shot developed with Merck delivers positive outcome in late-stage trial

Yahoo Finance News ·2h ago

Moderna shares double as cancer vaccine data rekindles investor hopes

Moderna shares double on skin cancer vaccine success →

Moderna shares double as cancer vaccine data rekindles investor hopes →

Moderna shares double on skin cancer vaccine success

Moderna shares double as cancer vaccine data rekindles investor hopes